Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Paul Haluska, Frank Worden, David Olmos, Donghua Yin, David Schteingart, Gretchen N. Batzel, M. Luisa Paccagnella, Johann S. De Bono, Antonio Gualberto, Gary D. Hammer

Research output: Contribution to journal › Article › peer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds